In ovarian cancer, lidocaine down-regulated SLC7A11 expression by increasing miR-382-5p expression (Fig. 1), to attenuate invasion and migration of ovarian cancer [93]. The gene discussed is SLC7A11; the disease is ovarian carcinoma.